These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8044339)

  • 1. Is there an optimal thrombolytic regimen?
    Collen D
    Coron Artery Dis; 1994 Apr; 5(4):287-91. PubMed ID: 8044339
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is time running out on streptokinase?
    Sane DC; Little WC
    J Am Coll Cardiol; 1998 Mar; 31(4):780-2. PubMed ID: 9525546
    [No Abstract]   [Full Text] [Related]  

  • 4. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe use of thrombolysis in the elderly.
    Wittry MD; Thornton TA; Chaitman BR
    Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-dose thrombolytic following myocardial infarction.
    Furniss SS; Millar RN; Commerford PJ
    S Afr Med J; 1997 Feb; 87(2):179, 182. PubMed ID: 9107231
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolytic treatment for elderly patients with acute myocardial infarction.
    Estess JM; Topol EJ
    Heart; 2002 Apr; 87(4):308-11. PubMed ID: 11906993
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversies in thrombolysis--choice of the agent.
    Horak AR; Commerford PJ
    S Afr Med J; 1990 Jan; 77(2):60-1. PubMed ID: 2104993
    [No Abstract]   [Full Text] [Related]  

  • 9. Another coronary reperfusion regimen.
    Simoons ML
    Lancet; 1995 Aug; 346(8971):324-5. PubMed ID: 7623525
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thrombolytic therapy of acute heart infarct in 1988].
    Arnold AE; Simoons ML; Lubsen J
    Ned Tijdschr Geneeskd; 1989 Feb; 133(7):341-9. PubMed ID: 2522593
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiplatelet and antithrombin therapy.
    Fernández-Ortiz A; Jang IK; Fuster V
    Coron Artery Dis; 1994 Apr; 5(4):297-305. PubMed ID: 8044341
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze.
    Zahn R; Rustige J; Koch A; Schiele R; Burczyk U; Schuster S; Harmjanz D; Boppert D; Gottwik M; Neuhaus KL; Senges J
    Am J Cardiol; 1997 Nov; 80(10):1339-43. PubMed ID: 9388110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current problems with thrombolytic agents in the management of acute myocardial infarction.
    Pancholia AK; Sambi RS; Krishna CK
    Indian Heart J; 2009; 61(5):476-9. PubMed ID: 20635767
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy.
    Califf RM; Stump D; Topol EJ; Mark DB
    Am Heart J; 1999 May; 137(5):S90-3. PubMed ID: 10220606
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic role of plasminogen-activator-inhibitor-1 (PAI-1) levels in treatment with streptokinase of patients with acute myocardial infarction.
    De Lorenzo F; Xiao H; Kakkar VV
    Clin Cardiol; 2000 Dec; 23(12):877-8. PubMed ID: 11129670
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-effect relationship estimation for thrombolytic therapy in acute myocardial infarction.
    Boissel JP; Leizorovicz A; Peyrieux JC
    Semin Thromb Hemost; 1987 Apr; 13(2):181-5. PubMed ID: 3114886
    [No Abstract]   [Full Text] [Related]  

  • 19. Overutilization and underutilization of thrombolysis in routine clinical practice.
    Sleight P
    J Am Coll Cardiol; 2001 May; 37(6):1588-9. PubMed ID: 11345369
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in thrombolytic therapy for acute myocardial infarction.
    Topol EJ
    J Clin Pharmacol; 1987 Oct; 27(10):735-45. PubMed ID: 3123526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.